Kazuro Sugimura

Kazuro Sugimura

Auto-generated profile, based on publicly available information

Kazuro Sugimura

Division of Radiology, Department of Radiology, Kobe University Graduate School of Medicine, Kobe, Japan

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2009 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
DTDaisuke Takenaka
Daisuke Takenaka
YOYoshiharu Ohno
Yoshiharu Ohno
KMKeiko Matsumoto
Keiko Matsumoto
NANobukazu Aoyama
Nobukazu Aoyama
YOYumiko Onishi
Yumiko Onishi
KSKazuro Sugimura
Kazuro Sugimura
Purpose: To prospectively compare the capability for bone metastasis assessment of whole‐body diffusion‐weighted imaging (DWI), magnetic resonance imaging (MRI) without and with DWI, [18F] fluoro‐2‐D‐glucose positron emission tomography with computed tomography (FDG‐PET/CT) and bone scintigraphy in non‐small cell carcinoma (NSCLC) patients.Materials and Methods: In all, 115 consecutive NSCLC patients (66 men, 49 women; mean age 72 years) prospectively underwent whole‐body MRI, PET/CT, and bone scintigraphy before treatment. For each method, probability of metastasis was independently assessed by using a 5‐point visual scoring system on a per‐site basis. Receiver operating characteristic (ROC)‐based positive tests were used to determine the practical threshold value for each method on a per‐site basis. Sensitivities, specificities, and accuracies were then compared on a per‐site and per‐patient basis by means of McNemar's test.Results: When the practical threshold values were adapted, specificity and accuracy of whole‐body MRI with DWI were significantly higher than those of bone scintigraphy and PET/CT (P < 0.05). On a per‐patient basis, specificity and accuracy of whole‐body MRI with DWI were significantly higher than those of bone scintigraphy (P < 0.05).Conclusion: Whole‐body MRI with DWI can be used for bone metastasis assessment of NSCLC patients as accurate as bone scintigraphy and/or PET/CT. J. Magn. Reson. Imaging 2009;30:298–308.

23 November 2010 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
JSJessica C Sieren
Jessica C Sieren
YOYoshiharu Ohno
Yoshiharu Ohno
HKHisanobu Koyama
Hisanobu Koyama
KSKazuro Sugimura
Kazuro Sugimura
GMGeoffrey McLennan
Geoffrey McLennan
This review compares the emerging technologies and approaches in the application of magnetic resonance (MR) and computed tomography (CT) imaging for the assessment of pulmonary nodules and staging of malignant findings. Included in this review is a brief definition of pulmonary nodules and an introduction to the challenges faced. We have highlighted the current status of both MR and CT for the early detection of lung nodules. Developments are detailed in this review for the management of pulmonary nodules using advanced imaging, including: dynamic imaging studies, dual energy CT, computer aided detection and diagnosis, and imaging assisted nodule biopsy approaches which have improved lung nodule detection and diagnosis rates. Recent advancements linking in vivo imaging to corresponding histological pathology are also highlighted. In vivo imaging plays a pivotal role in the clinical staging of pulmonary nodules through TNM assessment. While CT and positron emission tomography (PET)/CT are currently the most commonly clinically employed modalities for pulmonary nodule staging, studies are presented that highlight the augmentative potential of MR. J. Magn. Reson. Imaging 2010;32:1353–1369.

1 February 2008 in American Journal of Roentgenology
Verified
Journal Article
Closed access
YOYoshiharu Ohno
Yoshiharu Ohno
HKHisanobu Koyama
Hisanobu Koyama
MNMunenobu Nogami
Munenobu Nogami
DTDaisuke Takenaka
Daisuke Takenaka
SMSumiaki Matsumoto
Sumiaki Matsumoto
KSKazuro Sugimura
Kazuro Sugimura
OBJECTIVE. The purpose of the present study is to prospectively compare the capability of dynamic oxygen-enhanced MRI and quantitative CT for pulmonary functional loss assessment and clinical stage classification of smoking-related chronic obstructive pulmonary disease (COPD). SUBJECTS AND METHODS. Ten nonsmoking and 61 consecutive smoking-related COPD subjects underwent dynamic oxygen-enhanced MRI, CT, and pulmonary function tests. COPD subjects were classified into four clinical stages on the basis of the ATS–ERS guidelines. Wash-in time and relative enhancement ratio maps were generated by pixel-by-pixel analyses. Mean wash-in time and relative enhancement ratio were determined as averages of region of interest (ROI) measurements. CT-based functional lung volumes were measured on quantitative CT using the density-masked CT technique. For comparison of assessment capability for smoking-related functional loss, the three parameters were correlated with the percentage predicted forced expiratory volume in 1 second (%FEV1) and the percentage predicted diffusing capacity of the lung for carbon monoxide corrected for alveolar volume (%DLCO/Va). To determine the clinical stage classification capability, these parameters were statistically compared for nonsmoking subjects and all clinical stages of smoking-related COPD subjects. RESULTS. Correlation between mean wash-in time and %FEV1 (r = –0.74, p < 0.0001) and between mean relative enhancement ratio and %DLCO /Va (r = 0.66, p < 0.0001) was better than that between CT-based functional lung volume and either %FEV1 (r = 0.61, p < 0.0001) or %DLCO/Va (r = 0.56, p < 0.0001). Mean wash-in time showed a significant difference between nonsmoking and smoking-related COPD subjects at all clinical stages (p < 0.05). CONCLUSION. Dynamic oxygen-enhanced MRI has potential for pulmonary functional loss assessment and clinical stage classification of smoking-related COPD as does quantitative CT.

16 October 2013 in Annals of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
KKKazuhiro Kitajima
Kazuhiro Kitajima
YSYuko Suenaga
Yuko Suenaga
YUYoshiko Ueno
Yoshiko Ueno
TKTomonori Kanda
Tomonori Kanda
TMTetsuo Maeda
Tetsuo Maeda
KSKazuro Sugimura
Kazuro Sugimura
Background: To evaluate the diagnostic value of retrospective image fusion from pelvic magnetic resonance imaging (MRI) and 18F-fluorodeoxyglucose positron emission tomography (PET) in detecting intra-pelvic recurrence of gynecological tumor. Methods: Thirty patients with a suspicion of recurrence of gynecological malignancy underwent inline contrast-enhanced PET/computed tomography (CT) and pelvic contrast-enhanced MRI for restaging. Diagnostic performance about the local recurrence, pelvic lymph node and bone metastasis and peritoneal lesion of PET/low-dose non-enhanced CT (PET/ldCT), PET/full-dose contrast-enhanced CT (PET/ceCT), contrast-enhanced MRI, and retrospective image fusion from PET and MRI (fused PET/MRI) were evaluated by two experienced readers. Final diagnoses were obtained by histopathological examinations, radiological imaging and clinical follow-up for at least 6 months. McNemar test was employed for statistical analysis. Results: Documented positive locally recurrent disease, pelvic lymph node and bone metastases, and peritoneal dissemination were present in 53.3, 26.7, 10.0, and 16.7 %, respectively. Patient-based sensitivity for detecting local recurrence, pelvic lymph node and bone metastasis and peritoneal lesion were 87.5, 87.5, 100 and 80.0 %, respectively, for fused PET/MRI, 87.5, 62.5, 66.7 and 60.0 %, respectively, for contrast-enhanced MRI, 62.5, 87.5, 66.7 and 80.0 %, respectively, for PET/ceCT, and 50.0, 87.5, 66.7 and 60.0 %, respectively, for PET/ldCT. The sensitivity of diagnosing local recurrence by fused PET/MRI was significantly better than that of PET/ldCT (p = 0.041). The patient-based sensitivity, specificity and accuracy for the detection of intra-pelvic recurrence/metastasis were 91.3, 100 and 93.3 % for fused PET/MRI, 82.6, 100 and 86.7 % for contrast-enhanced MRI, 82.6, 100 and 86.7 % for PET/ceCT and 78.3, 85.7 and 80.0 % for PET/ldCT. Conclusion: Fused PET/MRI combines the individual advantages of MRI and PET, and is a valuable technique for assessment of intra-pelvic recurrence of gynecological cancers.


1 June 2013 in American Journal of Roentgenology
Verified
Journal Article
Closed access
YOYoshiharu Ohno
Yoshiharu Ohno
Mizuho NishioMizuho Nishio
Mizuho Nishio
HKHisanobu Koyama
Hisanobu Koyama
YFYasuko Fujisawa
Yasuko Fujisawa
TYTakeshi Yoshikawa
Takeshi Yoshikawa
KSKazuro Sugimura
Kazuro Sugimura
OBJECTIVE. The objective of our study was to prospectively compare the capability of dynamic area-detector CT analyzed with different mathematic methods and PET/CT in the management of pulmonary nodules. SUBJECTS AND METHODS. Fifty-two consecutive patients with 96 pulmonary nodules underwent dynamic area-detector CT, PET/CT, and microbacterial or pathologic examinations. All nodules were classified into the following groups: malignant nodules (n = 57), benign nodules with low biologic activity (n = 15), and benign nodules with high biologic activity (n = 24). On dynamic area-detector CT, the total, pulmonary arterial, and systemic arterial perfusions were calculated using the dual-input maximum slope method; perfusion was calculated using the single-input maximum slope method; and extraction fraction and blood volume (BV) were calculated using the Patlak plot method. All indexes were statistically compared among the three nodule groups. Then, receiver operating characteristic analyses were used to compare the diagnostic capabilities of the maximum standardized uptake value (SUVmax) and each perfusion parameter having a significant difference between malignant and benign nodules. Finally, the diagnostic performances of the indexes were compared by means of the McNemar test. RESULTS. No adverse effects were observed in this study. All indexes except extraction fraction and BV, both of which were calculated using the Patlak plot method, showed signifi-cant differences among the three groups (p < 0.05). Areas under the curve of total perfusion calculated using the dual-input method, pulmonary arterial perfusion calculated using the dual-input method, and perfusion calculated using the single-input method were significantly larger than that of SUVmax (p < 0.05). The accuracy of total perfusion (83.3%) was significantly greater than the accuracy of the other indexes: pulmonary arterial perfusion (72.9%, p < 0.05), systemic arterial perfusion calculated using the dual-input method (69.8%, p < 0.05), perfusion (66.7%, p < 0.05), and SUVmax (60.4%, p < 0.05). CONCLUSION. Dynamic area-detector CT analyzed using the dual-input maximum slope method has better potential for the diagnosis of pulmonary nodules than dynamic area-detector CT analyzed using other methods and than PET/CT.